1. Home
  2. FULT vs WVE Comparison

FULT vs WVE Comparison

Compare FULT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulton Financial Corporation

FULT

Fulton Financial Corporation

HOLD

Current Price

$19.96

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$14.49

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULT
WVE
Founded
1882
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
FULT
WVE
Price
$19.96
$14.49
Analyst Decision
Hold
Strong Buy
Analyst Count
4
16
Target Price
$20.75
$29.94
AVG Volume (30 Days)
1.8M
7.4M
Earning Date
01-21-2026
11-10-2025
Dividend Yield
3.88%
N/A
EPS Growth
20.91
N/A
EPS
1.91
N/A
Revenue
$1,230,470,000.00
$109,230,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.37
$16.00
P/E Ratio
$10.25
N/A
Revenue Growth
9.56
103.75
52 Week Low
$14.33
$5.28
52 Week High
$21.40
$21.73

Technical Indicators

Market Signals
Indicator
FULT
WVE
Relative Strength Index (RSI) 56.49 49.37
Support Level $19.09 $14.46
Resistance Level $20.08 $19.50
Average True Range (ATR) 0.37 1.43
MACD -0.10 -0.62
Stochastic Oscillator 50.97 5.50

Price Performance

Historical Comparison
FULT
WVE

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: